跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 117,107 条关于
“fibrotic lung disease”
全部
117,107
临床试验
92,064
药物
1,739
机构
238
资讯
23,066
2年前
Nerandomilast: A Novel PDE4B Inhibitor Shows Promise in Treating Idiopathic Pulmonary Fibrosis
7个月前
MiNK Therapeutics Identifies iNKT Cell Depletion as Key Mechanism in Advanced Idiopathic Pulmonary Fibrosis
11个月前
Vicore Pharma's Buloxibutid Receives Orphan Drug Designation in Japan for Idiopathic Pulmonary Fibrosis Treatment
6个月前
Inhaled CRISPR-Cas9 Nanoparticles Target STING1 in Alveolar Macrophages to Reverse Pulmonary Fibrosis in Mice
2年前
Nerandomilast Shows Promise in Phase 3 Trial for Idiopathic Pulmonary Fibrosis
去年
Foresee Pharmaceuticals Launches Phase 2 Trial of Mirivadelgat for Pulmonary Hypertension Associated with Interstitial Lung Disease
18天前
Specialized Lung Vein Cells Actively Drive Pulmonary Fibrosis, Revealing a New Therapeutic Target
3个月前
TLR5 Receptor Identified as Key Protective Pathway in Idiopathic Pulmonary Fibrosis, Mouse Studies Show Therapeutic Promise
去年
Qureight's AI Imaging Platform to Support Avalyn's Inhaled Pirfenidone Trial in Pulmonary Fibrosis
8个月前
Boehringer Ingelheim Advances First-in-Class IL-11 Inhibitor BI 765423 to Phase II Trial for Idiopathic Pulmonary Fibrosis
第 1 页,共 2307 页
上一页
下一页